Delivering the SDGs: focus on industry’s actions in the fight against AMR

This event underlined the key role of the fight against AMR to ensure we deliver on SDG 3 (but also 1, 2 and 8) and focused specifically on how the life sciences industry could contribute: What actions have already been undertaken, where does industry have the most added-value, where do we need to further collaborations to succeed?

Experts from diverse life sciences shared their perspective on how their business can contribute specifically, what are their respective strengths and where gaps remain. In addition, global health experts offered their recommendations to set aspirational goals for the industry and incentives further collaborations with governments.

The AMR Industry Alliance has worked with SustainAbility to deliver its first progress report. The report compiles the results of how members of are meeting the Alliance’s goals, in four different areas: Research and Science, Access, Appropriate Use, and Environment. It is the first attempt to aggregate and report the diverse industry activities relating the development of AMR. This first report has been launched at this event and serves to benchmark our progress, set targets for the future and identify gaps where further efforts may be required.

  • The video-recording of the event is available here.
  • The write-up of the event is available here.

Moderator: Dr. Ilona Kickbusch, Director of the Global Health Centre and adjunct professor at the Graduate Institute of International and Development Studies, Geneva


Introduction Mr. Thomas Cueni, Director General, IFPMA, Chair, AMR Industry Alliance
Keynote speaker
Dr. Marc Sprenger, Director of the AMR Secretariat, World Health Organization
Progress Report
Mrs. Denise Delaney, Director, Sustainability
Panel 1:
Findings and good practices from the 4 commitments areas of the AMR Industry Declaration
  • Mr. Gary M Cohen, Executive Vice President, Global Health and President, BD Foundation
  • Dr. Sanjay Kakkar, MD, MSc, MPH, CEO, Peptilogics, Inc.
  • Mr. Bruce Altevogt, Senior Director of Science Policy and Science Advocacy, Pfizer
Panel 2:
Setting targets for the future and identifying potential collaborations with the private sector
  • Mr. Marc Sprenger, Director of the AMR Secretariat, World Health Organization
  • Mrs. Martha Gyansa, Lutterodt, Director of Pharmaceutical Services and Chief Pharmacist of Ghana
  • Mr. Thomas Cueni, Director General, IFPMA, Chair, AMR Industry Alliance
  • Dr. Manica Balasegaram, Director, Global Antibiotic Research & Development (GARDP)
  • Dr. Catharina Boehme, CEO, Foundation for Innovative New Diagnostics


when 18/01/2018 12:00 - 14:30
where La Maison de la Paix, Chemin Eugène-Rigot 2, 102 Genève
RSVP info@amrindustryalliance.org or on the Graduate Institute website: http://graduateinstitute.ch/lang/en/pid/8646-1/_/events/globalhealth/delivering-the-sdgs-focus-on-ind
Registration http://graduateinstitute.ch/lang/en/pid/8646-1/_/events/globalhealth/delivering-the-sdgs-focus-on-ind